Paediatric Integrase Inhibitor Use in a Real-Life Setting: A Single-Centre Cohort Experience 2009-2018.

Yara-Natalie AboErika RefsumNicola MackieHermione LyallGareth Tudor-WilliamsCaroline Foster

Published in: Clinical drug investigation (2019)

INSTI-based regimens were generally efficacious and well tolerated in this paediatric cohort, with 4/26 discontinuations due to INSTI-attributed adverse events. Further post-marketing surveillance of INSTI use in children is warranted.

Keyphrases

intensive care unit
emergency department
public health
young adults